针刺与二甲双胍治疗胰岛素抵抗型多囊卵巢综合征女性的疗效与安全性比较:随机对照试验的网络Meta分析
本研究通过贝叶斯网络Meta分析比较针刺与二甲双胍治疗多囊卵巢综合征(PCOS)伴胰岛素抵抗(IR)女性的疗效与安全性。共纳入12项RCT(n=870),结果显示针刺与二甲双胍均能显著降低HOMA-IR,两者在改善糖代谢方面无统计学差异,但针刺不良事件更少。针刺可能作为PCOS伴IR患者的潜在替代疗法。
要点
- 针刺与二甲双胍均能显著降低PCOS伴IR患者的HOMA-IR水平。
- 两者在改善糖代谢方面无统计学差异,但针刺不良事件发生率更低。
- 针刺在所有结局的累积排序概率曲线下面积中排名较高,显示较好潜力。
核心结论
- 针刺可能作为PCOS伴IR女性的潜在替代疗法,与二甲双胍疗效相当且相对更安全。
- 由于目前证据不足,仍需进一步试验确认这些发现。
研究设计与样本
- 研究为贝叶斯网络Meta分析,检索PubMed、EMBASE、Web of Science、Cochrane、ClinicalTrials.gov及相关文献至2024年8月12日。
- 共纳入12项随机对照试验(RCT),总样本量n=870。
- 其中4项RCT比较针刺与二甲双胍,6项比较二甲双胍与对照干预(空白对照或安慰剂),2项比较针刺与假针刺。
主要发现
- 针刺(MD: -0.76, 95% CrI: -1.42, -0.03)和二甲双胍(MD: -0.74, 95% CrI: -1.28, -0.17)均显著降低IR水平(HOMA-IR)。
- 两种治疗方法在改善糖代谢方面无统计学差异。
- 针刺的不良事件更少(风险比: 0.13, 95% CrI: 0.01, 0.68)。
- 针刺在所有结局的累积排序概率曲线下面积(SUCRA)中排名较高,显示更好的有效性和安全性潜力。
关键数值与推荐
- 疗效指标包括HOMA-IR指数、空腹血糖、空腹胰岛素和不良事件发生率。
- 针刺降低HOMA-IR的MD为-0.76(95% CrI: -1.42, -0.03),二甲双胍的MD为-0.74(95% CrI: -1.28, -0.17)。
- 针刺不良事件的风险比为0.13(95% CrI: 0.01, 0.68)。
临床怎么用
- 对于PCOS伴IR女性,针刺可作为二甲双胍的潜在替代选择,尤其适用于关注不良事件风险的患者。
- 临床决策时应结合患者偏好和具体情况,并注意当前证据的局限性。
局限性
- 当前证据不足,需进一步试验确认针刺的疗效和安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to conduct a network meta-analysis (NMA) comparing the effectiveness and safety of traditional acupuncture with metformin. This study aims to identify an effective and safe alternative treatment for women with polycystic ovary syndrome (PCOS) complicated by insulin resistance (IR). METHODS: We searched PubMed, EMBASE, Web of Science, Cochrane, ClinicalTrials.gov, and relevant citations for eligible randomized controlled trials (RCTs) published up to August 12, 2024. Data extraction and bias assessment were performed by two independent reviewers, and Bayesian NMA was performed using the GeMTC package, with a random effects model. The NMA compared the effectiveness and safety of acupuncture with metformin which were measured using the Homeostasis Model Assessment Insulin Resistance (HOMA-IR) index, fasting plasma glucose, fasting insulin, and the incidence of adverse events (AEs). RESULTS: We included 12 RCTs (n = 870). Four RCTs compared acupuncture with metformin, six compared metformin with control interventions (blank control or placebo), and two compared acupuncture with sham acupuncture. Acupuncture (Mean difference (MD): -0.76, 95 % credible interval (CrI): -1.42, -0.03) and metformin (MD: -0.74, 95 % CrI: -1.28, -0.17) significantly reduced the IR level (HOMA-IR). No statistical difference was observed between both treatment methods in improving glucose metabolism; however, acupuncture had fewer AEs (risk ratio: 0.13, 95 % CrI: 0.01, 0.68). Acupuncture all ranked high in terms of surface under the cumulative ranking curve across all outcomes, thus demonstrating better effectiveness and safety potential. CONCLUSIONS: Acupuncture may be a potential alternative for PCOS women with IR, as it is equally effective, easier to perform, and relatively safer than metformin. Further trials are necessary to confirm these findings owing to the current lack of sufficient evidence.Protocol registration: PROSPERO, CRD42024581934.
引用
- Yan WL, Kan ZQ, Wang LQ, et al. Comparative effectiveness and safety of acupuncture vs metformin in insulin-resistant polycystic ovary syndrome women: A network meta-analysis of RCTs. Integr Med Res. 2025. PMID: 40487780. doi:10.1016/j.imr.2025.101148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。